COVID-19 and The Low Vision Community: Perspectives Of A Congenitally Blind Researcher – Dr. Mahadeo Sukhai
Dr. Sukhai shares his journey from congenitally blind newborn to visually impaired biomedical researcher with a deep passion for science and inclusion. Dr. Sukhai further highlights recent research data surrounding the impact of COVID-19 on people with low vision.
About the guest:
Dr. Mahadeo Sukhai is the world’s first congenitally blind biomedical research scientist. Mahadeo is Director of Research and Chief Inclusion and Accessibility Officer for the CNIB (Canadian National Institute for the Blind), having previously served as a researcher at the University Health Network in Toronto. Dr. Sukhai also holds an adjunct faculty appointment in the Department of Ophthalmology, School of Medicine, Queens University (Kingston, ON, Canada). In his role at CNIB, Mahadeo leads a significant research program focused on social determinants of health and inclusion for people living with sight loss in Canada. He also is responsible for organizational employee culture-building strategy related to inclusion, accessibility and employee wellness. Dr. Sukhai is the Principal Investigator for and co-author of “Creating a Culture of Accessibility in the Sciences,” a book based on his groundbreaking work on access to science within higher education, and serves as the principal investigator for national projects to understand the student experience for persons with disabilities, and to examine accessibility and inclusion within science education and healthcare. Dr. Sukhai co-founded IDEA-STEM, an organization dedicated to accessibility in science education, and INOVA, the international Network of researchers with Visual impairments and their Allies, a new professional society with the mission to improve accessibility and inclusion in the biomedical sciences for researchers with vision loss.